Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04997499 · ClinicalTrials.gov registry record · NA
Adolescent Subcutaneous (SQ) Injection Video Validation
A NA study of Contraception and Medication Compliance, sponsored by Tufts Medical Center.
- Active
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT04997499: Active NA study of Contraception and Medication Compliance, sponsored by Tufts Medical Center.
NCT04997499 is a NA study of Contraception and Medication Compliance that is active but no longer recruiting, run by Tufts Medical Center. The registered enrollment target is 30 participants, below the 454-participant average among 72 other Contraception trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04997499, a NA study of Contraception and Medication Compliance, is active but no longer recruiting, sponsored by Tufts Medical Center.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a study to determine if a video that utilizes a peer to teach self administration of subcutaneous depot medroxyprogesterone is both effective and well accepted by adolescent patients who are already receiving ongoing treatment with depot medroxyprogesterone by a medical provider via an inter muscular injection. Self administration can be done at home and therefore offers an alternative to traveling to a medical office.
Primary Outcome
This measure is coded 1 if the patient successfully completes self-injection at the first session after watching the video. Otherwise, the measure is coded 0. Incomplete attempts, such preparing for but not completing the injection, will be coded 0.
Conditions Studied
Interventions
- BEHAVIORAL watch an instructional video
Study Locations (1)
Massachusetts
- Tufts Medical Center - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2021-09-29 |
| Est. Completion | 2026-12 |
| Phase | NA |
What the registry record for NCT04997499 still lists
NCT04997499 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 454-participant average among 72 other Contraception trials with a reported enrollment target (93% lower).
The record links to 3 conditions, with Contraception appearing as the primary indexed condition, and to 1 intervention - of which watch an instructional video is the first listed.
NCT04997499 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT04997499 about?
NCT04997499 is a clinical study titled "Adolescent Subcutaneous (SQ) Injection Video Validation". This is a study to determine if a video that utilizes a peer to teach self administration of subcutaneous depot medroxyprogesterone is both effective and well accepted by adolescent patients who are already receiving ongoing treatment with depot medroxyprogesterone by a medical provider via an inter...
What is the current status of trial NCT04997499?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2021-09-29. Estimated completion is 2026-12.
What conditions does trial NCT04997499 study?
This clinical trial studies the following conditions: Contraception, Medication Compliance, Self-Evaluation.
What interventions are being tested in trial NCT04997499?
The interventions under investigation include: watch an instructional video (BEHAVIORAL).
Who is sponsoring clinical trial NCT04997499?
This trial is sponsored by Tufts Medical Center, which has 169 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04997499 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Contraception
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04997499's enrollment target sits among peer trials
30 59th of 72 higher than 13 of 72 other Contraception trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Contraception trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Patient-clinical Linkages to Improve Trust and Engagement in Postpartum Healthcare
RECRUITING · NA
-
Empathy Through Pain Control: Lidocaine Paracervical Block for IUD Placements
RECRUITING · NA
-
Hormonal Contraception Access Through Pharmacist Prescribing Implementation
RECRUITING · NA
-
Prospective Multi-Center Trial for FemBloc Permanent Birth Control
RECRUITING · NA
-
Contraceptive Efficacy Study of Ovaprene
RECRUITING · NA
-
Intervening on Women's Health for Rural Young Cancer Survivors
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI